Does ETOPOSIDE Cause Diffuse large b-cell lymphoma refractory? 244 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 244 reports of Diffuse large b-cell lymphoma refractory have been filed in association with ETOPOSIDE (Avopef). This represents 0.5% of all adverse event reports for ETOPOSIDE.
244
Reports of Diffuse large b-cell lymphoma refractory with ETOPOSIDE
0.5%
of all ETOPOSIDE reports
40
Deaths
68
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma refractory From ETOPOSIDE?
Of the 244 reports, 40 (16.4%) resulted in death, 68 (27.9%) required hospitalization, and 16 (6.6%) were considered life-threatening.
Is Diffuse large b-cell lymphoma refractory Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ETOPOSIDE. However, 244 reports have been filed with the FAERS database.
What Other Side Effects Does ETOPOSIDE Cause?
Off label use (6,495)
Febrile neutropenia (5,966)
Disease progression (3,776)
Drug ineffective (3,687)
Neutropenia (3,641)
Thrombocytopenia (3,085)
Product use in unapproved indication (2,774)
Anaemia (2,586)
Pyrexia (2,453)
Sepsis (2,211)
What Other Drugs Cause Diffuse large b-cell lymphoma refractory?
RITUXIMAB (461)
CYCLOPHOSPHAMIDE (360)
DOXORUBICIN (345)
VINCRISTINE (331)
PREDNISONE (214)
EPCORITAMAB-BYSP (198)
CYTARABINE (193)
DEXAMETHASONE (170)
CISPLATIN (156)
IFOSFAMIDE (154)
Which ETOPOSIDE Alternatives Have Lower Diffuse large b-cell lymphoma refractory Risk?
ETOPOSIDE vs ETORICOXIB
ETOPOSIDE vs ETRASIMOD ARGININE
ETOPOSIDE vs ETRAVIRINE
ETOPOSIDE vs EUCALYPTOL\MENTHOL\METHYL SALICYLATE\THYMOL
ETOPOSIDE vs EVEROLIMUS